John Bullen

Company: AstraZeneca

Job title: Associate Director, ADC/RC Target and Platforms Discovery Lead

Seminars:

Leveraging Novel Proteogenomic Approaches & Machine Learning to Accelerate Radioconjugate Target Discovery 11:30 am

Identifying and validating therapeutic targets using surface proteomics and tailored data analytics Integration of surface proteomics into proteogenomic computational methods to enhance target selection paired with patient, disease and drug biology Exploring the “deep proteome” and other proteomic data types to unlock novel target spaceRead more

day: Conference Day One